SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hua Li, Andy Wolfe, Seth Septer, Genea Edwards, Xiaobo Zhong, Ahmad Bashar Abdulkarim, Sarangarajan Ranganathan, Udayan Apte, Deregulation of Hippo kinase signalling in Human hepatic malignancies, Liver International, 2012, 32, 1
  2. 2
    Diego F. Calvisi, Maddalena Frau, Maria L. Tomasi, Francesco Feo, Rosa M. Pascale, Deregulation of signalling pathways in prognostic subtypes of hepatocellular carcinoma: Novel insights from interspecies comparison, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2012, 1826, 1, 215

    CrossRef

  3. 3
    Haibo Bai, Mariana F. Gayyed, Dora M. Lam-Himlin, Alison P. Klein, Suresh K. Nayar, Yang Xu, Mehtab Khan, Pedram Argani, Duojia Pan, Robert A. Anders, Expression of Yes-associated protein modulates Survivin expression in primary liver malignancies, Human Pathology, 2012,

    CrossRef

  4. 4
    Chuan-Ming XU, Fu-Sheng WAN, Hippo signaling pathway in mammals:a new therapeutic target for tumors, Hereditas (Beijing), 2012, 34, 3, 269

    CrossRef

  5. 5
    Chengying Jiang, Fangke Hu, Yanhong Tai, Jingli Du, Beibei Mao, Zengqiang Yuan, Yan Wang, Lixin Wei, The tumor suppressor role of Src homology phosphotyrosine phosphatase 2 in hepatocellular carcinoma, Journal of Cancer Research and Clinical Oncology, 2012, 138, 4, 637

    CrossRef

  6. 6
    Wanjin Hong, Kun-Liang Guan, The YAP and TAZ transcription coactivators: key downstream effectors of the mammalian Hippo pathway, Seminars in Cell & Developmental Biology, 2012,

    CrossRef

  7. 7
    T Mizuno, H Murakami, M Fujii, F Ishiguro, I Tanaka, Y Kondo, S Akatsuka, S Toyokuni, K Yokoi, H Osada, Y Sekido, YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes, Oncogene, 2012,

    CrossRef

  8. 8
    Xu Zhi, Dong Zhao, Zhongmei Zhou, Rong Liu, Ceshi Chen, YAP Promotes Breast Cell Proliferation and Survival Partially through Stabilizing the KLF5 Transcription Factor, The American Journal of Pathology, 2012, 180, 6, 2452

    CrossRef

  9. 9
    Y. Bao, K. Nakagawa, Z. Yang, M. Ikeda, K. Withanage, M. Ishigami-Yuasa, Y. Okuno, S. Hata, H. Nishina, Y. Hata, A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription, Journal of Biochemistry, 2011, 150, 2, 199

    CrossRef

  10. 10
    Raquel Urtasun, Maria U. Latasa, Maria I. Demartis, Stella Balzani, Saioa Goñi, Oihane Garcia-Irigoyen, Maria Elizalde, Maria Azcona, Rosa M. Pascale, Francesco Feo, Paulette Bioulac-Sage, Charles Balabaud, Jordi Muntané, Jesus Prieto, Carmen Berasain, Matias A. Avila, Connective tissue growth factor autocriny in human hepatocellular carcinoma: Oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein–mediated activation, Hepatology, 2011, 54, 6
  11. 11
    Melchiorre Cervello, Dimcho Bachvarov, Antonella Cusimano, Francesca Sardina, Antonina Azzolina, Nadia Lampiasi, Lydia Giannitrapani, James A. McCubrey, Giuseppe Montalto, COX-2-Dependent and COX-2-Independent Mode of Action of Celecoxib in Human Liver Cancer Cells, OMICS: A Journal of Integrative Biology, 2011, 15, 6, 383

    CrossRef

  12. 12
    Mengxin Yin, Lei Zhang, Hippo signaling: A hub of growth control, tumor suppression and pluripotency maintenance, Journal of Genetics and Genomics, 2011, 38, 10, 471

    CrossRef

  13. 13
    T. Tordjmann, Hippo signalling: Liver size regulation and beyond, Clinics and Research in Hepatology and Gastroenterology, 2011, 35, 5, 344

    CrossRef

  14. You have free access to this content14
    Yoshitaka Sekido, Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation, Pathology International, 2011, 61, 6
  15. 15
    Y. Bao, Y. Hata, M. Ikeda, K. Withanage, Mammalian Hippo pathway: from development to cancer and beyond, Journal of Biochemistry, 2011, 149, 4, 361

    CrossRef

  16. 16
    Lihua Min, Baokun He, Lijian Hui, Mitogen-activated protein kinases in hepatocellular carcinoma development, Seminars in Cancer Biology, 2011, 21, 1, 10

    CrossRef

  17. 17
    Kai Breuhahn, Gregory Gores, Peter Schirmacher, Strategies for hepatocellular carcinoma therapy and diagnostics: Lessons learned from high throughput and profiling approaches, Hepatology, 2011, 53, 6
  18. 18
    Bin Zhao, Karen Tumaneng, Kun-Liang Guan, The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal, Nature Cell Biology, 2011, 13, 8, 877

    CrossRef

  19. 19
    X Zhang, J George, S Deb, J L Degoutin, E A Takano, S B Fox, D D L Bowtell, K F Harvey, The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene, Oncogene, 2011, 30, 25, 2810

    CrossRef

  20. 20
    Hélène Gilgenkrantz, Voie Hippo-YAP et foie, médecine/sciences, 2011, 27, 5, 479

    CrossRef

  21. 21
    Brent A. Orr, Haibo Bai, Yazmin Odia, Deepali Jain, Robert A. Anders, Charles G. Eberhart, Yes-Associated Protein 1 Is Widely Expressed in Human Brain Tumors and Promotes Glioblastoma Growth, Journal of Neuropathology and Experimental Neurology, 2011, 70, 7, 568

    CrossRef

  22. 22
    Lei Zhang, Dong-xia Ye, Hong-ya Pan, Kui-jie Wei, Li-zhen Wang, Xu-dong Wang, Guo-fang Shen, Zhi-yuan Zhang, Yes-associated protein promotes cell proliferation by activating Fos Related Activator-1 in oral squamous cell carcinoma, Oral Oncology, 2011, 47, 8, 693

    CrossRef

  23. 23
    Marta A. Kowalik, Christian Saliba, Monica Pibiri, Andrea Perra, Giovanna M. Ledda-Columbano, Ivana Sarotto, Elena Ghiso, Silvia Giordano, Amedeo Columbano, Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice, Hepatology, 2011, 53, 6
  24. 24
    Cédric Polesello, Fernando Roch, Vanessa Gobert, Marc Haenlin, Lucas Waltzer, Animal Models of Human Disease, 2011,

    CrossRef

  25. 25
    M Z Xu, S W Chan, A M Liu, K F Wong, S T Fan, J Chen, R T Poon, L Zender, S W Lowe, W Hong, J M Luk, AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma, Oncogene, 2010, 30, 10, 1229

    CrossRef

  26. 26
    Lars Zender, Augusto Villanueva, Victoria Tovar, Daniela Sia, Derek Y. Chiang, Josep M. Llovet, Cancer gene discovery in hepatocellular carcinoma, Journal of Hepatology, 2010, 52, 6, 921

    CrossRef

  27. You have free access to this content27
    Yoshitaka Sekido, Genomic abnormalities and signal transduction dysregulation in malignant mesothelioma cells, Cancer Science, 2010, 101, 1
  28. 28
    L. Lu, Y. Li, S. M. Kim, W. Bossuyt, P. Liu, Q. Qiu, Y. Wang, G. Halder, M. J. Finegold, J.-S. Lee, R. L. Johnson, Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver, Proceedings of the National Academy of Sciences, 2010, 107, 4, 1437

    CrossRef

  29. 29
    Julja Burchard, Chunsheng Zhang, Angela M Liu, Ronnie T P Poon, Nikki P Y Lee, Kwong-Fai Wong, Pak C Sham, Brian Y Lam, Mark D Ferguson, George Tokiwa, Ryan Smith, Brendan Leeson, Rebecca Beard, John R Lamb, Lee Lim, Mao Mao, Hongyue Dai, John M Luk, microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma, Molecular Systems Biology, 2010, 6,

    CrossRef

  30. 30
    Angela M. Liu, Ronnie T.P. Poon, John M. Luk, MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties, Biochemical and Biophysical Research Communications, 2010, 394, 3, 623

    CrossRef

  31. 31
    J Avruch, D Zhou, J Fitamant, N Bardeesy, Mst1/2 signalling to Yap: gatekeeper for liver size and tumour development, British Journal of Cancer, 2010, 104, 1, 24

    CrossRef

  32. You have free access to this content32
    Yang Wang, Qianze Dong, Qingfu Zhang, Zixuan Li, Enhua Wang, Xueshan Qiu, Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer, Cancer Science, 2010, 101, 5
  33. 33
    Duojia Pan, The Hippo Signaling Pathway in Development and Cancer, Developmental Cell, 2010, 19, 4, 491

    CrossRef

  34. 34
    K.-P. Lee, J.-H. Lee, T.-S. Kim, T.-H. Kim, H.-D. Park, J.-S. Byun, M.-C. Kim, W.-I. Jeong, D. F. Calvisi, J.-M. Kim, D.-S. Lim, The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis, Proceedings of the National Academy of Sciences, 2010, 107, 18, 8248

    CrossRef

  35. 35
    T. Muramatsu, I. Imoto, T. Matsui, K.-i. Kozaki, S. Haruki, M. Sudol, Y. Shimada, H. Tsuda, T. Kawano, J. Inazawa, YAP is a candidate oncogene for esophageal squamous cell carcinoma, Carcinogenesis, 2010, 32, 3, 389

    CrossRef

  36. 36
    K. Breuhahn, P. Schirmacher, Development, Differentiation and Disease of the Para-Alimentary Tract, 2010,

    CrossRef